For all the hype corporate giving can generate, getting a handle on it isn’t easy. Still, there are some clear leaders, encompassing the nation’s biggest banks, tech giants, pharmaceutical companies and retailers.
Read MorePhilanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.
Read MoreWith the pandemic shedding further light on the many social factors that shape health inequality, the Gilead Foundation is launching a three-pronged funding program to advance health justice.
Read MoreCorporate grant support has soared, more than tripling since 2012. But major companies back LGBTQ communities in many other ways, too. We look at the big picture of this giving, along with the bottom-line considerations that drive it.
Read MoreGilead Sciences is a leading player in HIV/AIDS funding in the U.S. South, with a major grantmaking program aimed at tackling an epidemic that’s still raging in this part of the country. Where’s the money going?
Read MoreGilead Sciences recently announced a 10-year, $100 million commitment to combat HIV/AIDS in the South—the latest funder to respond to a disturbingly high prevalence of infections in the region.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
